title: Pharmacotherapy for chronic facial pain.
abstract: The clinical usefulness of a drug therapy program for the management of chronic head and neck pain requires an understanding of the conditions in which the program will be used. The practitioner should remember that drug therapy is not the keystone of chronic pain management, but only a useful adjunct that should be eliminated or reduced as soon as feasible. The other various modalities for chronic pain management, which include physical therapy, relaxation therapy, transcutaneous electrical nerve stimulation, injection therapy, and occlusal reconstruction should be utilized to their fullest extent if the patient is to achieve success.
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003729:Dental Care; D005145:Face; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000523:psychology; D010919:Placebos; D014653:Vascular Headaches / Q000188:drug therapy
chemical_list: D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D010919:Placebos